These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15708732)

  • 21. Morphologic diagnosis of "vascular dementia" - a critical update.
    Jellinger KA
    J Neurol Sci; 2008 Jul; 270(1-2):1-12. PubMed ID: 18455191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral small-vessel disease and decline in information processing speed, executive function and memory.
    Prins ND; van Dijk EJ; den Heijer T; Vermeer SE; Jolles J; Koudstaal PJ; Hofman A; Breteler MM
    Brain; 2005 Sep; 128(Pt 9):2034-41. PubMed ID: 15947059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal size and dementia in stroke patients: the Sydney stroke study.
    Sachdev PS; Chen X; Joscelyne A; Wen W; Altendorf A; Brodaty H
    J Neurol Sci; 2007 Sep; 260(1-2):71-7. PubMed ID: 17482210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia.
    Haglund M; Passant U; Sjöbeck M; Ghebremedhin E; Englund E
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):681-7. PubMed ID: 16802283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case study of strategic infarct dementia investigated with the cognitive assessment system.
    McCrea SM; Scott M
    Brain Cogn; 2002 Jul; 49(2):207-10. PubMed ID: 15259391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI identifies MCI subtypes: vascular versus neurodegenerative.
    Meyer JS; Quach M; Thornby J; Chowdhury M; Huang J
    J Neurol Sci; 2005 Mar; 229-230():121-9. PubMed ID: 15760630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1H MRS in stroke patients with and without cognitive impairment.
    Ross AJ; Sachdev PS; Wen W; Valenzuela MJ; Brodaty H
    Neurobiol Aging; 2005 Jun; 26(6):873-82. PubMed ID: 15718046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic.
    van der Flier WM; van der Vlies AE; Weverling-Rijnsburger AW; de Boer NL; Admiraal-Behloul F; Bollen EL; Westendorp RG; van Buchem MA; Middelkoop HA
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1060-6. PubMed ID: 16250078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depressive symptoms and white matter changes in patients with dementia.
    Lind K; Jonsson M; Karlsson I; Sjögren M; Wallin A; Edman A
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):119-25. PubMed ID: 16416468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia.
    Traykov L; Baudic S; Raoux N; Latour F; Rieu D; Smagghe A; Rigaud AS
    J Neurol Sci; 2005 Mar; 229-230():75-9. PubMed ID: 15760623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD).
    Graban A; Bednarska-Makaruk M; Bochyńska A; Lipczyńska-Łojkowska W; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):116-8. PubMed ID: 19339023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Education and the cognitive decline associated with MRI-defined brain infarct.
    Elkins JS; Longstreth WT; Manolio TA; Newman AB; Bhadelia RA; Johnston SC
    Neurology; 2006 Aug; 67(3):435-40. PubMed ID: 16894104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular factors and progression of cognitive decline in elderly people].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2005; 39(5):987-95. PubMed ID: 16358597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
    Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
    Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging.
    Knipp SC; Matatko N; Wilhelm H; Schlamann M; Thielmann M; Lösch C; Diener HC; Jakob H
    Ann Thorac Surg; 2008 Mar; 85(3):872-9. PubMed ID: 18291160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.